第一单位：
Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA.
作者：
Chang-Han,Lee [1]
;
Tae Hyun,Kang [2]
;
Ophélie,Godon [3]
;
Makiko,Watanabe [1]
;
George,Delidakis [1]
;
Caitlin M,Gillis [3]
;
Delphine,Sterlin [3]
;
David,Hardy [4]
;
Michel,Cogné [5]
;
Lynn E,Macdonald [6]
;
Andrew J,Murphy [6]
;
Naxin,Tu [6]
;
Jiwon,Lee [7]
;
Jonathan R,McDaniel [1]
;
Emily,Makowski [8]
;
Peter M,Tessier [9]
;
Aaron S,Meyer [10]
;
Pierre,Bruhns [11]
;
George,Georgiou [12]
作者单位：
Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA.
[1]
Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA.;Department of Applied Chemistry, Kookmin University, Seoul, Republic of Korea.
[2]
Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERMF-75015, Paris, France.
[3]
Experimental Neuropathology Unit, Infection and Epidemiology Department, Institut Pasteur, 25, rue du Docteur Roux, 75015, Paris, France.
[4]
Limoges University, Limoges, France.
[5]
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
[6]
Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.
[7]
Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.
[8]
Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA.;Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
[9]
Department of Bioengineering, University of California at Los Angeles, Los Angeles, CA, USA.
[10]
Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERMF-75015, Paris, France. bruhns@pasteur.fr.
[11]
Department of Chemical Engineering, University of Texas at Austin, Austin, TX, USA. gg@che.utexas.edu.;Department of Molecular Bioscience, University of Texas at Austin, Austin, TX, USA. gg@che.utexas.edu.;Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA. gg@che.utexas.edu.
[12]
DOI
10.1038/s41467-019-13458-x
PMID
31767870
发布时间
2020-05-28
换一批
